June 20, 2024 04:54 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Sending shockwaves, man kills girlfriend in full public view with a spanner in Mumbai | 'It will be you versus me in Maharashtra polls': Uddhav Thackeray challenges PM Modi | With Modi's re-election, Justin Trudeau wants to engage on some 'very serious issues' | Fire breaks out at iconic Hollong Bungalow in Bengal's Jalpaiguri | Portion of under-construction bridge collapses in Bihar's Araria
Australia recognises Bharat Biotech's Covaxin for travel purposes
Covaxin
Image Credit: Twitter/IndianEmbassyTR

Australia recognises Bharat Biotech's Covaxin for travel purposes

| @indiablooms | 01 Nov 2021, 02:38 pm

Canberra/New Delhi/IBNS: Easing curbs on international travel, Australia has recognised Indian biotechnology company Bharat Biotech's anti-COVID-19 vaccine, Covaxin, for travel purposes.

Australia has also approved a Chinese vaccine, manufactured by Sinopharm.

The Australian government said in a statement, "Today, the TGA determined that Covaxin (manufactured by Bharat Biotech, India) and BBIBP-CorV (manufactured by Sinopharm, China) vaccines would be 'recognised' for the purpose of establishing a traveller's vaccination status. This recognition is for travellers aged 12 and over who have been vaccinated with Covaxin, and those 18 to 60 who have been vaccinated with BBIBP-CorV.

In recent weeks, the TGA has obtained additional information demonstrating these vaccines provide protection and potentially reduce the likelihood that an incoming traveller would transmit COVID-19 infection to others while in Australia or become acutely unwell due to COVID-19. The supporting information has been provided to the TGA from the vaccine sponsor and/or the World Health Organisation."

Earlier, the Indian version of Oxford vaccine, Covishield, and China's Coronavac were approved by Australia for travelling to the country.

"Importantly, recognition of Covaxin, and BBIBP-CorV, along with the previously announced recognition of Coronavac (manufactured by Sinovac, China) and Covishield (manufactured by AstraZeneca, India), means many citizens of China and India as well as other countries in our region where these vaccines have been widely deployed will now be considered fully vaccinated on entry to Australia.

"This will have significant impacts for the return of international students, and travel of skilled and unskilled workers to Australia. TGA's updated report on its advice about vaccines not registered in Australia but in use internationally can be found at: COVID-19 vaccines not registered in Australia but in current international use - TGA advice on recognition'," it added.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.